Evidence map›Paper›PMID 38062477›Full record

ArticleBiology direct2023

Loss of the centrosomal protein ALMS1 alters lipid metabolism and the regulation of extracellular matrix-related processes.

Brais Bea-Mascato, Eduardo Gómez-Castañeda, Yara E Sánchez-Corrales, Sergi Castellano, Diana Valverde

Open access · goldAbstract read
In one paragraph

Article in Biology direct, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Brais Bea-MascatoCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, Vigo, 36310, Spain.
Eduardo Gómez-CastañedaMolecular and Cellular Immunology Section, Great Ormond Street Institute of Child Health, University College London, London, UK.
Yara E Sánchez-CorralesGenetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London, UK.
Sergi CastellanoGenetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London, UK.
Diana ValverdeCINBIO Facultad de Biología, Universidad de Vigo, Campus As Lagoas-Marcosende s/n, Vigo, 36310, Spain. dianaval@uvigo.es.
Great Ormond Street Hospital · GBGalicia Sur Biomedical Foundation · ESGenomics England · GBServicio Gallego de Salud · ES

Funding

Instituto de Salud Carlos III PI15/00049Instituto de Salud Carlos III PI19/00332Ministerio de Ciencia, Innovación y Universidades FPU17/01567Xunta de Galicia ED431G-2019/06
6 · The paper itself

Abstract

backgroundAlström syndrome (ALMS) is a rare autosomal recessive disease that is associated with mutations in ALMS1 gene. The main clinical manifestations of ALMS are retinal dystrophy, obesity, type 2 diabetes mellitus, dilated cardiomyopathy and multi-organ fibrosis, characteristic in kidneys and liver. Depletion of the protein encoded by ALMS1 has been associated with the alteration of different processes regulated via the primary cilium, such as the NOTCH or TGF-β signalling pathways. However, the cellular impact of these deregulated pathways in the absence of ALMS1 remains unknown.

methodsIn this study, we integrated RNA-seq and proteomic analysis to determine the gene expression profile of hTERT-BJ-5ta ALMS1 knockout fibroblasts after TGF-β stimulation. In addition, we studied alterations in cross-signalling between the TGF-β pathway and the AKT pathway in this cell line.

resultsWe found that ALMS1 depletion affects the TGF-β pathway and its cross-signalling with other pathways such as PI3K/AKT, EGFR1 or p53. In addition, alterations associated with ALMS1 depletion clustered around the processes of extracellular matrix regulation and lipid metabolism in both the transcriptome and proteome. By studying the enriched pathways of common genes differentially expressed in the transcriptome and proteome, collagen fibril organisation, β-oxidation of fatty acids and eicosanoid metabolism emerged as key processes altered by the absence of ALMS1. Finally, an overactivation of the AKT pathway was determined in the absence of ALMS1 that could be explained by a decrease in PTEN gene expression.

conclusionALMS1 deficiency disrupts cross-signalling between the TGF-β pathway and other dependent pathways in hTERT-BJ-5ta cells. Furthermore, altered cross-signalling impacts the regulation of extracellular matrix-related processes and fatty acid metabolism, and leads to over-activation of the AKT pathway.

Indexed as

Alstrom SyndromeDiabetes Mellitus, Type 2Cell Cycle ProteinsExtracellular MatrixHumansLipid MetabolismPhosphatidylinositol 3-KinasesProteomeProteomicsProto-Oncogene Proteins c-aktTransforming Growth Factor betaALMS1 protein, humanCell Cycle ProteinsPhosphatidylinositol 3-KinasesProteomeProto-Oncogene Proteins c-aktTransforming Growth Factor betaAKTALMS1Alström syndromeCiliopathyECMLipid metabolismPrimary ciliaTGF-β

Identifiers

PMID38062477
PMCPMC10704752
OpenAlexW4389484427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.